臨床神経学

原著

Prevalence of Neurological Complications in Japanese Patients with AIDS after the Introduction of HAART

Asako Yoritaka, M.D., Keiko Ohta, M.D. and Shuji Kishida, M.D.

Department of Neurology, Tokyo Metropolitan Komagome Hospital 〔Honkomagome 3-18-22, Bunkyo-ku, Tokyo 113-8677, Japan〕

We investigated trends in neurological complications of infection with human immunodeficiency virus (HIV) in Japan after the introduction of highly active antiretroviral therapy (HAART). Two questionnaire surveys were performed in hospitals treating acquired immunodeficiency syndrome (AIDS) to compare two periods: immediately after the introduction of HAART (1999-2001); and a few years later (2002-3). Neurological complications accompanied 15.9% in 1999-2001 and 9.8% in 2002-3. Neurological complications developed without HAART in about 80% of cases. Neurological complications developed as the first AIDS-defining disease for 8.3% of AIDS patients in 1999-2001 and for 5.4% in 2002-3. Prevalences of HIV encephalopathy and myelopathy decreased markedly over the study period, as reported in other developed nations. However, prevalences of cytomegalovirus encephalitis, PML and primary brain lymphoma did not decrease. PML and primary brain lymphoma occurred in patients who received HAART and whose CD4 counts were relatively high during the study period. This is probably related to the extended survival of HIV-infected individuals after the introduction of HAART as a worldwide therapy, and the reactivation of viremia or latent infection persisting within the central nervous system.

(臨床神経, 47:491−496, 2007)
key words:human immunodeficiency virus, highly active antiretroviral therapy, acquired immunodeficiency syndrome, central nervous system, epidemiology

(受付日:2007年2月19日)